Medtech grants in Germany

Between cycles

Runs research teams and institutions for EIT Health Catapult Edition in biotechnology, medical technology, and artificial intelligence.

Between cycles

Funds early-career researchers building an independent research team and pursuing frontier research through an ERC Starting Grant hosted at a public or private research organisation.

Between cycles

Funds a €7M platform giving adolescent and young adult cancer patients and survivors personalized digital tools for coping and psychological support.

Between cycles

Funds a €15M project that turns microbiome signals into a test for spotting cancer risk years ahead of any symptoms.

Between cycles

Funds three €5M projects that build earlier, AI-assisted palliative care models for cancer patients and test them in real clinical and home-based settings.

Between cycles

Funds a €5M programme that pairs EU and Associated Country research institutions with Ukrainian cancer centres for joint training and staff exchanges.

Between cycles

Funds up to four €8-9M grants for teams building AI-driven digital models of a patient's cancer to predict how it develops and guide personalised treatment.

Between cycles

Offers early-career deep-tech researchers a free venture-creation and pre-incubation programme with training, coaching and a European bootcamp.

Between cycles

Offers European health founders early support from EIT Health through mentorship, networks, and commercialization guidance.

Closed

Funds bottom-up research for breakthrough deep-tech, any field of science.

Closed

Supports European deep-tech ventures advancing laboratory research toward validated prototypes and near-market technologies.

Closed

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

Closed

Funds up to two projects that design AI-in-health training programmes jointly with universities, VET providers, hospitals and industry, delivered through Europe's AI screening-centre network.

Closed

Funds early clinical trials of therapies built from the molecules cells secrete rather than the cells themselves, aiming for an off-the-shelf alternative to cell therapy.

Closed

Funds a flagship project that federates EU health data and pilots AI tools for cardiovascular risk prediction, prevention and personalised care.

Closed

Funds AI teams building generative-AI tools for clinical-dataset enhancement or automotive crash-test case generation, paying up to €100,000 in prizes after an initial €28,500 concept-stage award.

Closed

Pays cash prizes to teams that build and validate generative AI solutions for enhancing clinical datasets or generating automatic test cases from crash databases.

Closed

Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.

Closed

Funds hospital consortia to pilot cloud-based AI systems that read medical scans for cancer and cardiovascular screening, with clinicians validating every result.

Closed

Funds research into unmanned vehicles that can find, assess and evacuate wounded soldiers in mass-casualty and CBRN combat zones.

Closed

Funds wearable devices and apps, paired with behavioural coaching, that help 12-to-25-year-olds build habits that prevent the most common non-cancer chronic diseases later in life.

Closed

Pays 200,000 euros to study bioengineering business ideas that use microgravity.

Closed

Funds international biotech R&D consortia through each country's own national funding scheme.

Closed

Funds small, SME-majority consortia running an early-phase clinical trial to move a biotech therapy, from antibodies to RNA therapies, from the lab towards the market.